WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...

WAYNE, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX) today announced the publication of data from a study comparing patient experience of those treated with the UroLift ® System ...

Five Studies Show Significant Relief and Improved Quality of Life with UroLift System The “Real-World Experience” study, which enrolled 156 patients at the Norfolk & Norwich University Hospital in the ...

Dr. Irina Jaeger, director of urology at University Hospitals Richmond Medical Center, is making UroLift treatment for benign prostatic hypertrophy, or BPH, available in the area for the first time.

Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting WAYNE, Pa., July 21, 2020 (GLOBE NEWSWIRE) -- ...

A surgical option which is minimally invasive and available as same-day outpatient procedure1,2,3 Following a positive Haute Autorité de Santé (HAS) assessment, a procedure code has been granted ...

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sponsored content: Enlarged prostate affects ...

WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new ...

A surgical option which is minimally invasive and available as same-day outpatient procedure 1,2,3 WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX)– Men in France living with Benign ...